SKYSTAR BIO-PHARMACEUTICAL CO
SKYSTAR BIO-PHARMACEUTICAL CO (SKBI) is a publicly traded company in the Unknown sector. Across all available filings, 7 corporate insiders have executed 14 transactions totaling $1.4M, demonstrating a bullish sentiment with $1.4M in net insider flow. The most recent transaction on May 26, 2015 involved a purchase of 63,900 shares valued at $185.9K.
SKBI Insider Activity Summary
Who Is Buying SKBI Stock?
No significant insider buying has been recorded for SKBI in the recent period.
Who Is Selling SKBI Stock?
No significant insider selling has been recorded for SKBI in the recent period.
Is SKYSTAR BIO-PHARMACEUTICAL CO Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for SKBI is bullish with an Insider Alignment Score of 100/100 and a net flow of $1.4M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
SKBI Frequently Asked Questions
Understanding SKBI Insider Activity
Insider trading at SKYSTAR BIO-PHARMACEUTICAL CO (SKBI) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 7 insiders are actively trading SKBI stock, having executed 14 transactions in the past 90 days. The most active insider is John M. Gregory (Executive), who has made 6 transactions totaling $1.4M.
Related Tools
Track SKYSTAR BIO-PHARMACEUTICAL CO Insider Activity
Get notified when executives and directors at SKBI file new Form 4 transactions